JP2003513942A5 - - Google Patents

Download PDF

Info

Publication number
JP2003513942A5
JP2003513942A5 JP2001536204A JP2001536204A JP2003513942A5 JP 2003513942 A5 JP2003513942 A5 JP 2003513942A5 JP 2001536204 A JP2001536204 A JP 2001536204A JP 2001536204 A JP2001536204 A JP 2001536204A JP 2003513942 A5 JP2003513942 A5 JP 2003513942A5
Authority
JP
Japan
Prior art keywords
composition
growth factor
vector
peptide
angiogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001536204A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003513942A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/030345 external-priority patent/WO2001034208A1/en
Publication of JP2003513942A publication Critical patent/JP2003513942A/ja
Publication of JP2003513942A5 publication Critical patent/JP2003513942A5/ja
Pending legal-status Critical Current

Links

JP2001536204A 1999-11-05 2000-11-03 インビボ遺伝子送達による心血管疾患を処理するための技術および組成物 Pending JP2003513942A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US43515699A 1999-11-05 1999-11-05
US09/435,156 1999-11-05
US60908000A 2000-06-30 2000-06-30
US09/609,080 2000-06-30
PCT/US2000/030345 WO2001034208A1 (en) 1999-11-05 2000-11-03 Techniques and compositions for treating cardiovascular disease by in vivo gene delivery

Publications (2)

Publication Number Publication Date
JP2003513942A JP2003513942A (ja) 2003-04-15
JP2003513942A5 true JP2003513942A5 (https=) 2007-12-20

Family

ID=27030448

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001536204A Pending JP2003513942A (ja) 1999-11-05 2000-11-03 インビボ遺伝子送達による心血管疾患を処理するための技術および組成物

Country Status (10)

Country Link
EP (1) EP1225921A1 (https=)
JP (1) JP2003513942A (https=)
KR (1) KR20020049031A (https=)
CN (1) CN1433325A (https=)
AU (1) AU784392B2 (https=)
CA (1) CA2389524A1 (https=)
EA (1) EA008538B1 (https=)
HK (1) HK1048593A1 (https=)
NZ (1) NZ546670A (https=)
WO (1) WO2001034208A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034208A1 (en) * 1999-11-05 2001-05-17 The Regents Of The University Of California Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
US20030093147A1 (en) * 2001-11-13 2003-05-15 Ogle Matthew F. Medical devices that stimulate growth factor production
KR100562824B1 (ko) 2002-03-20 2006-03-23 주식회사 바이로메드 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자
PL195457B1 (pl) * 2002-08-05 2007-09-28 Zaklady Farm Polpharma Sa Kaseta ekspresyjna, dwucistronowy wektor plazmidowy, środek farmaceutyczny oraz ich zastosowanie
GB2437893A (en) * 2006-07-25 2007-11-07 Celladon Corp Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy
EP2559698B1 (en) * 2007-08-24 2014-11-12 Julius-Maximilians-Universität Würzburg Mutant double cyclized receptor peptides inhibiting beta 1-adrenoceptor antibodies
JP5579164B2 (ja) 2008-04-09 2014-08-27 ビロメッド カンパニー, リミテッド 凍結乾燥dna製剤、組成物、及び凍結乾燥dna製剤を製造する方法
WO2010078624A1 (en) * 2009-01-07 2010-07-15 Vegenics Limited Materials and methods for the treatment of hypertension
KR101006106B1 (ko) * 2009-06-04 2011-01-07 김현태 전·자기장 차단 전열선
US10155099B2 (en) 2009-09-21 2018-12-18 Cook Regentec Llc Method for infusing stem cells
CA2864100A1 (en) 2012-02-14 2013-08-22 The Regents Of The University Of California Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions
WO2013184782A2 (en) 2012-06-05 2013-12-12 Muffin Incorporated Catheter systems and methods useful for cell therapy
US10639351B2 (en) 2013-10-22 2020-05-05 Helixmith Co., Ltd. Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factor
US20210393805A1 (en) * 2018-05-16 2021-12-23 University Of Massachusetts Perfusion-based delivery of recombinant aav vectors for expression of secreted proteins
KR20210027493A (ko) 2018-07-19 2021-03-10 주식회사 헬릭스미스 네이키드 dna 유전자 요법을 위한 동결 건조된 약제학적 조성물
JP7717677B2 (ja) * 2019-08-07 2025-08-04 ノースウェスタン ユニバーシティ 心臓内遺伝子送達のための材料及び方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034208A1 (en) * 1999-11-05 2001-05-17 The Regents Of The University Of California Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
EA001616B1 (ru) * 1995-02-28 2001-06-25 Зе Риджентс Оф Зи Юнивесити Оф Кэлифоньэ Способ лечения болезни сердца, способ лечения недостаточности периферических сосудов и способ ограничения доставки и экспрессии трансгенной конструкции в определенном органе или структуре
US5792453A (en) * 1995-02-28 1998-08-11 The Regents Of The University Of California Gene transfer-mediated angiogenesis therapy
AU745409B2 (en) * 1997-01-29 2002-03-21 Cornell Research Foundation Inc. Multiple site delivery of adenoviral vector for the induction of angiogenesis
KR20010012313A (ko) * 1997-05-06 2001-02-15 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 혈관형성성 트랜스유전자의 생체내 송달에 의한 심장 질환및 심실 리모델링을 치료하기 위한 방법 및 조성물
JP2002502885A (ja) * 1998-02-11 2002-01-29 ザ・リージェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニア 増強された遺伝子送達のための、核酸および血管作用性薬剤の組合せ
EP1139751A4 (en) * 1998-12-28 2003-03-19 Arch Dev Corp EFFICIENT AND STABLE -I (IN VIVO) GENE TRANSFER TO CARDIOMYCETS USING RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS

Similar Documents

Publication Publication Date Title
JP2003513942A5 (https=)
US8178493B2 (en) Method for inducing angiogenesis in a heart of a patient
Mitsos et al. Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials
JP2003519097A5 (https=)
Bobek et al. Gene therapy of the ischemic lower limb—Therapeutic angiogenesis
Melillo et al. Gene therapy for collateral vessel development
US6329348B1 (en) Method of inducing angiogenesis
Boodhwani et al. The future of therapeutic myocardial angiogenesis
Fukuda et al. Angiogenic strategy for human ischemic heart disease: brief overview
JP2002502885A5 (https=)
CA2289600A1 (en) Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes
US7709450B2 (en) Stimulation of vascularization with VEGF-B-186
Stegmann New approaches to coronary heart disease: induction of neovascularisation by growth factors
CN102755638A (zh) Aggf1在制备促进血管形成的药物中的用途
Sim et al. Therapeutic angiogenesis for coronary artery disease
Symes et al. Angiogenesis: potential therapy for ischaemic disease
Isner Manipulating angiogenesis against vascular disease
JP2009517343A (ja) 組織損傷のための幹細胞因子療法
Webster Therapeutic angiogenesis: a case for targeted, regulated gene delivery
Bashir et al. Angiogenic gene therapy: pre-clinical studies and phase I clinical data
Fedak et al. Angiogenesis: protein, gene, or cell therapy?
Stegmann et al. Combined Local Angiogenesis and Surgical Revascularization for
Shuman et al. THE GENE THERAPEUTIC CORRECTION OF CORONARY INSUFFICIENCY
Miraliakbari et al. Therapeutic angiogenesis: appropriate for clinical use?
JP2005097118A (ja) Hgf遺伝子からなる細胞移植定着促進剤